Track DMK Pharmaceuticals's current cash ($1.1M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
DMK Pharmaceuticals (DMK) currently reports a current cash of $1.1M as of December 2022. That compares with $23M in the prior-year period — down 95.3% year over year. Use the charts on this page to explore DMK Pharmaceuticals's current cash history and peer comparisons.
DMK Pharmaceuticals's current cash decreased from $23M to $1.1M — a 95.3% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
DMK Pharmaceuticals reported $1.1M in current cash as of December 2022. That compares with $23M in the prior-year period — down 95.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DMK Pharmaceuticals, and consider following DMK for alerts when major investors trade the stock.
DMK Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMK with unrelated industries.